Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-06-22

FDA Approved: DULERA — Original Application (Organon LLC)

View source ↗

Summary

FDA approves the original application for DULERA, a fixed-dose inhaled corticosteroid/long-acting beta-agonist combination (mometasone furoate and formoterol fu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DULERA (MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE)

Snippet

ORIG AP for DULERA (MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE)